We are now looking for a paid Research Assistant as master's thesis worker in universal speech enhancement for speech-based health biomarkers.

Supporting amyotrophic lateral sclerosis (ALS) mobility and flexibility through range of motion (ROM) exercises is an important part of maintaining overall wellness. Gentle ROM exercises can help ...

The actress shared how she “locked in” to spearhead her ex’s care, and do battle with insurance companies Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously appeared in Billboard ...

Even though actor Rebecca Gayheart said she went through a lot of tumult in her 15-year-old marriage to “Grey’s Anatomy” star Eric Dane, she said he’s still family, as she describes how she has become ...

Actor Eric Dane got real about what it’s like to live with ALS, and candidly discussed on Tuesday the range of emotional and physical repercussions of the devastating diagnosis. The “Euphoria” actor ...

Eric Dane has no desire to quit acting, even amid his battle with amyotrophic lateral sclerosis (ALS). Following his appearance on "Brilliant Minds," the "Euphoria" actor appeared on a Tuesday, Dec. 2 ...

Rebecca Gayheart is giving a glimpse into her family. Seven months after Eric Dane shared that he was diagnosed with amyotrophic lateral sclerosis (ALS), his estranged wife—with whom he shares ...

People in certain states in America appear to be more likely than others to develop devastating neurological diseases, a new study has indicated. Lou Gehrig's disease—also known as amyotrophic lateral ...

Eric Dane has been raising awareness about ALS after going public with his diagnosis earlier this year. The Euphoria and Grey's Anatomy star revealed in April that he'd been diagnosed with ALS ...

Eric Dane is exploring his journey with ALS in a new TV role. The “Euphoria” star, who announced his diagnosis with the neurodegenerative disease earlier this year, is set to guest star as a patient ...

EKZ-102, Eikonizo Therapeutics‘s experimental oral therapy for amyotrophic lateral sclerosis (ALS), is on track to enter early clinical testing in 2026, according to an announcement from the company.